These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7193020)

  • 1. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetropium: characterization of antimuscarinic and spasmolytic properties.
    Schiavone A; Schiavi GB; De Conti L; Micheletti R; Sagrada A; Hammer R; Giachetti A
    Arzneimittelforschung; 1985; 35(5):796-9. PubMed ID: 4026901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels.
    Gilani AH; Khan AU; Raoof M; Ghayur MN; Siddiqui BS; Vohra W; Begum S
    Fundam Clin Pharmacol; 2008 Feb; 22(1):87-99. PubMed ID: 18251725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of "selective" antimuscarinic agents on gastric acid secretion and motility.
    Subissi A; Guelfi M; Maggi CA; Meli A
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):313-9. PubMed ID: 3161479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
    Oyasu H; Yamamoto T; Sato N; Sawada T; Ozaki R; Mukai T; Ozaki T; Nishii M; Sato H; Fujiwara T
    Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic action of pirenzepine (Gastrozepin) on isolated gastrointestinal tract smooth muscles.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 1983; 5(3):171-5. PubMed ID: 6688455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
    Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A
    Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of smooth muscle relaxation by rociverine.
    D'Agostino G; Zonta F; Santagostino Barbone MG; Grana E; Brunori P; Subissi A
    Arzneimittelforschung; 1984; 34(5):584-9. PubMed ID: 6540576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine.
    Kachur JF; Peterson JS; Carter JP; Rzeszotarski WJ; Hanson RC; Noronha-Blob L
    J Pharmacol Exp Ther; 1988 Dec; 247(3):867-72. PubMed ID: 2849672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticholinergic action of neuroleptics and antidepressives on the guinea pig ileum. Comparison with atropine and pirenzepine].
    Alvarez Gonzalez FJ; Carvajal Garcia-Pando A; Casas Gonzalez MT; Gonzalez Martinez de Zarate JL; Velasco Martin A
    J Pharmacol; 1984; 15(2):177-84. PubMed ID: 6145814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the cholinolytic activity of pramiverine].
    Enenkel HJ; Müller-Calgan H; Schorscher E
    Arzneimittelforschung; 1976 Apr; 26(4b):690-6. PubMed ID: 821493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antispasmodic activity of the tertiary base of Daucus carota, Linn. seeds.
    Gambhir SS; Sen SP; Sanyal AK; Das PK
    Indian J Physiol Pharmacol; 1979; 23(3):225-8. PubMed ID: 521127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
    Testa R; Guarneri L; Bernasconi P; Angelico P; Ibba M; Poggesi E; Meli A
    Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N; Hofferber E
    Arzneimittelforschung; 1980; 30(12):2135-9. PubMed ID: 6111325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.